Zydus Lifesciences Gets Usfda Nod For Generic Drug

Zydus Lifesciences Gets Usfda Nod For Generic Drug

By, Admin 4 October 2022

Zydus Was One Of The First Applicants To Submit A Substantially Complete Anda (Abbreviated New Drugs Application) With A Paragraph Iv Certification For Mirabegron Extended-Release Tablets, 25 Mg And 50 Mg And I, Therefore,E Eligible For 180 Days Of Shared Generic Drug Exclusivity For The DrugZydus Lifesciences On Monday Said It Has Received The Usfda'S Final Nod To Market Its Generic Version Of Mirabegron Extended-Release Tablets Used To Treat Overactive Bladder, With 180 Days Of Shared Generic Drug Exclusivity. The Final Approval Granted By The Us Food And Drug Administration (Usfda) To The Company'S Us Arm Zydus Pharmaceuticals Inc Is For The Tablets Of Strengths 25 Mg And 50 Mg, It Said In A Regulatory Filing. Zydus Was One Of The First Applicants To Submit A Substantially Complete Anda (Abbreviated New Drugs Application) With A Paragraph Iv Certification For Mirabegron Extended-Release Tablets, 25 Mg And 50 Mg And I, Therefore,E Eligible Mirabegron Zydus Pharmaceuticals Inc Zydus Drug For Mirabegron Health News For 180 Days Of Shared Generic Drug Exclusivity For The Drug, It Added

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!